Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Menorrhagia × elagolix × Clear all

Phase

Phase 3 4 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 1 Leiomyoma 1

Interventions

ulipristal acetate 1 elagolix 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Ibuprofen 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03886220 2022-03-31

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

AbbVie

Phase 4 Completed

82 enrolled 10 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡